Glucose Baxter (Glucose, Anhydrous)

Q: What is the primary clinical purpose of Glucose Baxter when given intravenously?

Glucose Baxter provides an immediate source of glucose to raise blood sugar levels and supply energy, especially in patients who cannot receive nutrition orally.

Q: In which patient populations is Glucose Baxter commonly used for parenteral nutrition?

It is commonly used in critically ill patients, postoperative individuals, and those with gastrointestinal disorders who require intravenous carbohydrate supplementation.

Q: How does Glucose Baxter help in the management of hypoglycemia?

By delivering glucose directly into the bloodstream, the solution rapidly increases plasma glucose concentrations, correcting low blood sugar levels.

Q: What monitoring is recommended during an infusion of Glucose Baxter?

Frequent checks of blood glucose, serum electrolytes, and fluid balance are recommended to detect hyperglycemia, electrolyte shifts, or fluid overload.

Q: Can Glucose Baxter be mixed with other intravenous medications in the same line?

Mixing should be avoided with acidic solutions, calcium gluconate, or other drugs that may precipitate; separate lines are preferred.

Q: What are the signs of a serious allergic reaction to Glucose Baxter?

Symptoms may include rash, itching, swelling, difficulty breathing, or anaphylaxis, and require immediate medical attention.

Q: Is Glucose Baxter suitable for patients with renal impairment?

Caution is advised; renal function should be evaluated because excess glucose can affect fluid balance and electrolyte status.

Q: How does rapid infusion of Glucose Baxter affect potassium levels?

Rapid glucose infusion can drive potassium into cells, potentially causing transient hypokalemia; potassium levels should be monitored.

Q: What precautions should be taken for patients with cardiac failure?

Assess cardiac status and limit total fluid volume to avoid overload, as the solution adds both glucose and fluid to the circulation.

Q: Should Glucose Baxter be used together with insulin therapy?

If insulin is administered concurrently, glucose infusion rates must be adjusted and blood glucose monitored closely to prevent severe hyper- or hypoglycemia.

Glucose Baxter is an intravenous solution for injection that contains glucose, anhydrous as its sole active ingredient. It is supplied in a sterile liquid form without a specified strength label, and is marketed in the European Union for prescription use. As a carbohydrate drug, it is classified under parenteral nutrition and is intended to provide an immediate source of energy when administered intravenously to patients.

Manufacturer / TM Owner

Baxter Deutschland Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glucose Baxter is used in clinical settings where rapid glucose supplementation is required.

Management of hypoglycemia in patients unable to take oral glucose.
Component of parenteral nutrition regimens for patients who cannot receive enteral feeding.
Support for fluid and electrolyte balance during intravenous therapy.
Energy source during surgical procedures or critical care when oral intake is suspended.
Temporary glucose provision during diagnostic imaging procedures that require fasting.
Adjunctive therapy for patients with metabolic disorders that impair endogenous glucose production.

Side Effects

When administered intravenously, Glucose Baxter may be associated with a range of observed effects, most of which are mild and transient.

Common

Mild hyperglycemia that resolves with monitoring.
Local irritation at the injection site.
Nausea or vomiting if infused rapidly.
Electrolyte shifts such as mild hyponatremia.
Transient increase in serum osmolality.

Serious

Severe hyperglycemia leading to osmotic diuresis.
Allergic reactions including rash, itching, or anaphylaxis.
Fluid overload in patients with compromised cardiac function.
Metabolic acidosis in patients receiving large volumes without adequate buffering.

Precautions & Warnings

Clinicians should consider several precautionary measures before prescribing Glucose Baxter to ensure patient safety and therapeutic effectiveness.

Assess baseline blood glucose and adjust infusion rate accordingly.
Evaluate renal and cardiac function to avoid fluid overload.
Monitor electrolytes, particularly sodium and potassium, during therapy.
Use caution in patients with known hypersensitivity to glucose solutions.
Avoid concurrent administration with high‑dose insulin without appropriate glucose monitoring.
Document infusion duration and total volume to prevent inadvertent over‑administration.
Ensure compatible IV tubing and avoid mixing with incompatible medications that may precipitate.

Avoid Interactions

Glucose Baxter may interact with other intravenous agents, and awareness of these interactions helps maintain stable metabolic conditions.

Avoid

Co‑administration with large volumes of dextrose‑containing solutions without adjusting total carbohydrate load.
Simultaneous infusion of high‑dose insulin without real‑time glucose monitoring.
Mixing with acidic solutions (pH < 5) which can cause degradation of glucose.

Use with caution

Concurrent potassium chloride infusions, as rapid glucose administration can shift potassium intracellularly.
Calcium gluconate solutions, which may precipitate when mixed with high‑glucose concentrations.
Medications that affect renal clearance, such as aminoglycosides, requiring close monitoring of fluid balance.
Administration alongside beta‑adrenergic agonists, which may potentiate hyperglycemic response.

Frequently Asked Questions